Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus

Journal of Rheumatology

Volumn 28, Issue 2, 2001, Pages 370-372

  Higginbotham, E A ^a   Zimmerman, S A ^a   Howard, T A ^a   Schanberg, L ^a   Kredich, D ^a   Ware, R E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiphospholipid syndrome; Low molecular weight heparin; Lupus anticoagulant; Systemic lupus erythematosus; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTROGEN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; FEMALE; GENE MUTATION; HEPARINIZATION; HORMONAL CONTRACEPTION; HUMAN; HYPERCOAGULABILITY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; DNA MUTATIONAL ANALYSIS; FEMALE; HEPARIN; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MUTATION; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0035109484     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Pathogenesis and treatment of the antiphospholipid antibody syndrome
2. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management
3. Legg-Perthes disease in three siblings, two heterozygous and one homozygous for the factor V Leiden mutation
4. The relationship of mutations in the methylenetetrahydrofolate reductase, prothrombin, and plasminogen activator inhibitor-1 genes to plasma levels of homocysteine, prothrombin, and plasminogen activator inhibitor-1 levels in children and adults
5. Thrombophilic DNA mutations as independent risk factors for stroke and avascular necrosis in sickle cell anemia
6. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: A prospective analysis of 500 consecutive patients
7. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders
8. The relationship of antiphosphlipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: A cross-sectional study
9. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
10. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease
11. APC resistance in childhood thromboembolism: Diagnosis and clinical aspects
12. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus
13. Factor V Leiden: Should we screen oral contraceptive users and pregnant women
14. Homocysteine and atherothrombosis